Nautilus Biotechnolgy, Inc. (NAUT)
NASDAQ·Healthcare·Biotechnology
$0.95
-4.83%
Mkt Cap $123.70M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
Implied Upside
+162.9%
Consensus $2.50 vs current $0.95
NASDAQ·Healthcare·Biotechnology
$0.95
-4.83%
Mkt Cap $123.70M
No recent rating data.
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
+162.9%
Consensus $2.50 vs current $0.95